Skip to main content
Renata Sanders

Renata Sanders

Organization: Children’s Hospital of Philadelphia/University of Pennsylvania School of Medicine

Country: United States


Renata Arrington Sanders is the Division Chief of the Craig-Dalsimer Division of Adolescent Medicine at The Children’s Hospital of Philadelphia and Professor of Pediatrics and Medicine. Previously, Renata was in the Division of Adolescent & Young Adult Medicine at Johns Hopkins School of Medicine with a joint appointment in the Division of Infectious Diseases at the Johns Hopkins Bloomberg School of Public Health’s Departments of Epidemiology and Health, Behavior and Society. She served as the Medical Director of the Pediatric and Adolescent HIV/AIDS Program, Director of the PrEP Program in the Harriet Lane Clinic at Johns Hopkins Children’s Center, and co-Director of the Adolescent and Young Adult Scientific Working Group at Johns Hopkins Center for AIDS Research.

She has spent over 20 years caring for individuals living with HIV and who are vulnerable to HIV acquisition, cultivating research, practice and strategies that address the intersectional and multimodal needs of young people across their life course and into adulthood. The Centers for Disease Control and Prevention (CDC), Health Resources and Services Administration (HRSA), and National Institutes of Health National Institute on Drug Abuse (NIDA, 1R01DA043089-01, 1 R01 DA059022) fund her work. She currently serves on the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention & Treatment, the Research Review Committee of the American Board of Pediatrics, and Board of Directors of SIECUS, Sex Ed for Social Change and American Sexual Health Association. She is also cohort representative to the Transform Program for the Association of American Medical Colleges.

Renata has been an active member of the IAS since 2012, addressing the HIV pandemic through the advancement of scholarship, science and youth leaders. She has had the pleasure of serving on the Governing Council since 2020 (North America region) on the abstract, scholarship, IAS Stigma Advisory Board, Collaborative Initiative for Paediatric HIV Education and Research (CIPHER), Diversity, Equity and Inclusion, and programme committees. She was Lead Rapporteur for Track D at AIDS 2022, the 24th International AIDS Conference, has assisted with IAS Educational Fund webinars, and led a team of experts to help the IAS develop its first statement of commitment to providing gender-affirming care to all in 2023.

The IAS promotes the use of non-stigmatizing, people-first language. The translations are all automated in the interest of making our content as widely accessible as possible. Regretfully, they may not always adhere to the people-first language of the original version.